<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04551196</url>
  </required_header>
  <id_info>
    <org_study_id>202002118</org_study_id>
    <nct_id>NCT04551196</nct_id>
  </id_info>
  <brief_title>Management of Post-Tonsillectomy Pain in Pediatric Patients</brief_title>
  <official_title>Effectiveness of a Combined Acetaminophen and Ibuprofen Regimen for Management of Post-Tonsillectomy Pain in Pediatric Patients</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Washington University School of Medicine</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Washington University School of Medicine</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>Yes</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
    <is_us_export>No</is_us_export>
  </oversight_info>
  <brief_summary>
    <textblock>
      Single-center, randomized, open-label, non-inferiority treatment pilot study to evaluate the&#xD;
      effectiveness of a combined acetaminophen and ibuprofen regimen for treatment of&#xD;
      post-operative tonsillectomy pain in the pediatric population. 100 children undergoing&#xD;
      tonsillectomy will be randomized to receive either a combined acetaminophen and ibuprofen&#xD;
      regimen dosed every 6 hours or an alternating regimen of acetaminophen and ibuprofen dosed&#xD;
      every 3 hours.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">September 28, 2020</start_date>
  <completion_date type="Anticipated">December 2021</completion_date>
  <primary_completion_date type="Anticipated">December 2021</primary_completion_date>
  <phase>Phase 3</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <intervention_model_description>Single-center, randomized, open-label, non-inferiority treatment pilot study</intervention_model_description>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
    <masking_description>Open-label</masking_description>
  </study_design_info>
  <primary_outcome>
    <measure>Proportion of FLACC pain scores ≥7 from POD 1 through POD 3</measure>
    <time_frame>up to 3 days following consent</time_frame>
    <description>The proportion of FLACC (Faces, Legs, Activity, Cry, and Consolability scale) pain scores ≥7 from POD 1 through POD 3 compared between the combined and the alternating medication regimens.&#xD;
The FLACC scale is scored in a range of 0-10 with 0 representing no pain. The scale has five criteria (Faces, Legs, Activity, Cry, and Consolability), which are each assigned a score of 0, 1 or 2.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Proportion of FLACC pain scores ≥7 on each individual POD 1, 3, and 7</measure>
    <time_frame>3 separate individual days, will be completed days after the surgery</time_frame>
    <description>The proportion of FLACC (Faces, Legs, Activity, Cry, and Consolability scale) pain scores ≥7 on each individual POD 1, 3, and 7 compared between the combined and the alternating medication regimens.&#xD;
The FLACC scale is scored in a range of 0-10 with 0 representing no pain. The scale has five criteria (Faces, Legs, Activity, Cry, and Consolability), which are each assigned a score of 0, 1 or 2.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Proportion of cumulative FLACC pain scores ≥7 from POD 1 through POD 7</measure>
    <time_frame>up to 7 days following consent</time_frame>
    <description>The proportion of cumulative FLACC pain scores ≥7 from POD 1 through POD 7 compared between the combined and the alternating medication regimens.&#xD;
The FLACC scale is scored in a range of 0-10 with 0 representing no pain. The scale has five criteria (Faces, Legs, Activity, Cry, and Consolability), which are each assigned a score of 0, 1 or 2.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Proportion of Faces pain scores ≥8 on POD 1, 3, and 7</measure>
    <time_frame>3 separate individual days, will be completed days after the surgery</time_frame>
    <description>The proportion of Faces pain scores ≥8 on POD 1, 3, and 7 compared between the combined and the alternating medication regimens.&#xD;
The Faces scale shows a series of faces ranging from a happy face at 0, or &quot;no hurt&quot;, to a crying face at 10, which represents &quot;hurts like the worst pain imaginable&quot;. Based on the faces and written descriptions, the patient chooses the face that best describes their level of pain.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Proportion of cumulative Faces pain scores ≥8 from POD 1 through POD 7</measure>
    <time_frame>up to 7 days following consent</time_frame>
    <description>The proportion of cumulative Faces pain scores ≥8 from POD 1 through POD 7 compared between the combined and the alternating medication regimens.&#xD;
The Faces scale shows a series of faces ranging from a happy face at 0, or &quot;no hurt&quot;, to a crying face at 10, which represents &quot;hurts like the worst pain imaginable&quot;. Based on the faces and written descriptions, the patient chooses the face that best describes their level of pain.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Rescue Medication Usage through POD 3</measure>
    <time_frame>up to 3 days following consent</time_frame>
    <description>The proportion of rescue medication usage from POD 1 through POD 3 compared between the combined and the alternating medication regimens.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Rescue Medication Usage through POD 7</measure>
    <time_frame>up to 7 days following consent</time_frame>
    <description>The proportion of rescue medication usage from POD 1 through POD 7 compared between the combined and the alternating medication regimens.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Proportion of subjects that adhere to the assigned medication regimen</measure>
    <time_frame>up to 3 days following consent</time_frame>
    <description>Proportion of subjects that adhere to the assigned medication regimen compared between the combined and the alternating medication regimens as determined by the medication log that the participants return at the end of the study.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Adverse Events</measure>
    <time_frame>up to 7 days following consent</time_frame>
    <description>Incidence of adverse events</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">100</enrollment>
  <condition>Pain, Postoperative</condition>
  <condition>Tonsillar Hypertrophy</condition>
  <condition>Tonsillitis</condition>
  <arm_group>
    <arm_group_label>Alternating Regimen</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>A regimen of acetaminophen and ibuprofen alternating doses every 3 hours.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Combined Regimen</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>A regimen of acetaminophen and ibuprofen dosed together every 6 hours.</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Alternating Acetaminophen and Ibuprofen</intervention_name>
    <description>Subjects will alternate their post-operative acetaminophen and ibuprofen every 3 hours.</description>
    <arm_group_label>Alternating Regimen</arm_group_label>
    <other_name>Alternating regimen</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Combined Acetaminophen and Ibuprofen</intervention_name>
    <description>Subjects will take their post-operative acetaminophen and ibuprofen together every 6 hours.</description>
    <arm_group_label>Combined Regimen</arm_group_label>
    <other_name>Combined regimen</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  4 to 17 years of age at time of enrollment&#xD;
&#xD;
          -  Undergoing tonsillectomy with or without adenoidectomy&#xD;
&#xD;
          -  Able to provide informed consent from parent or legal guardian&#xD;
&#xD;
          -  Able to provide assent if subject is a minor of appropriate age&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Allergy to acetaminophen or ibuprofen&#xD;
&#xD;
          -  Inability for study participant to cooperate with pain assessments&#xD;
&#xD;
          -  Known pregnancy&#xD;
&#xD;
          -  Any condition which would make the participant, in the opinion of the investigator,&#xD;
             unsuitable for the study&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>4 Years</minimum_age>
    <maximum_age>17 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Alan Hifko, MD</last_name>
    <phone>314-273-0783</phone>
    <email>Ahifko@wustl.edu</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Micheal Montana, MD</last_name>
    <email>MontanaM@wustl.edu</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Saint Louis Children's Hospital</name>
      <address>
        <city>Saint Louis</city>
        <state>Missouri</state>
        <zip>63110</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Alan Hifko, MD</last_name>
      <phone>314-273-0783</phone>
      <email>Ahifko@wustl.edu</email>
    </contact>
    <investigator>
      <last_name>Micheal Montana, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>David Leonard, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <reference>
    <citation>Mitchell RB, Archer SM, Ishman SL, Rosenfeld RM, Coles S, Finestone SA, Friedman NR, Giordano T, Hildrew DM, Kim TW, Lloyd RM, Parikh SR, Shulman ST, Walner DL, Walsh SA, Nnacheta LC. Clinical Practice Guideline: Tonsillectomy in Children (Update). Otolaryngol Head Neck Surg. 2019 Feb;160(1_suppl):S1-S42. doi: 10.1177/0194599818801757.</citation>
    <PMID>30798778</PMID>
  </reference>
  <reference>
    <citation>Ingram DG, Friedman NR. Toward Adenotonsillectomy in Children: A Review for the General Pediatrician. JAMA Pediatr. 2015 Dec;169(12):1155-61. doi: 10.1001/jamapediatrics.2015.2016. Review.</citation>
    <PMID>26436644</PMID>
  </reference>
  <reference>
    <citation>National Prospective Tonsillectomy Audit Final Report. Royal College of Surgeons https://www.rcseng.ac.uk/library-and-publications/rcs-publications/docs/tonsillectomy-audit/</citation>
  </reference>
  <reference>
    <citation>Álvarez Palacios I, González-Orús Álvarez-Morujo R, Alonso Martínez C, Ayala Mejías A, Arenas Brítez O. Postoperative Pain in Adult Tonsillectomy: Is There Any Difference Between the Technique? Indian J Otolaryngol Head Neck Surg. 2017 Jun;69(2):187-193. doi: 10.1007/s12070-017-1058-9. Epub 2017 Jan 16.</citation>
    <PMID>28607888</PMID>
  </reference>
  <reference>
    <citation>Lauder G, Emmott A. Confronting the challenges of effective pain management in children following tonsillectomy. Int J Pediatr Otorhinolaryngol. 2014 Nov;78(11):1813-27. doi: 10.1016/j.ijporl.2014.08.011. Epub 2014 Aug 27. Review.</citation>
    <PMID>25241379</PMID>
  </reference>
  <reference>
    <citation>Tobias JD, Green TP, Coté CJ; SECTION ON ANESTHESIOLOGY AND PAIN MEDICINE; COMMITTEE ON DRUGS. Codeine: Time to Say &quot;No&quot;. Pediatrics. 2016 Oct;138(4). pii: e20162396. Epub 2016 Sep 19.</citation>
    <PMID>27647717</PMID>
  </reference>
  <reference>
    <citation>Kelly LE, Sommer DD, Ramakrishna J, Hoffbauer S, Arbab-Tafti S, Reid D, Maclean J, Koren G. Morphine or Ibuprofen for post-tonsillectomy analgesia: a randomized trial. Pediatrics. 2015 Feb;135(2):307-13. doi: 10.1542/peds.2014-1906.</citation>
    <PMID>25624387</PMID>
  </reference>
  <reference>
    <citation>Ismail Zaidan &amp; Amanda Lent. Post-Tonsillectomy Pain in Children: The Postcodeine Era. US Pharm. 41, 31-34 (2016).</citation>
  </reference>
  <reference>
    <citation>D'Souza JN, Schmidt RJ, Xie L, Adelman JP, Nardone HC. Postoperative nonsteroidal anti-inflammatory drugs and risk of bleeding in pediatric intracapsular tonsillectomy. Int J Pediatr Otorhinolaryngol. 2015 Sep;79(9):1472-6. doi: 10.1016/j.ijporl.2015.05.042. Epub 2015 Jul 2.</citation>
    <PMID>26164211</PMID>
  </reference>
  <reference>
    <citation>Lewis SR, Nicholson A, Cardwell ME, Siviter G, Smith AF. Nonsteroidal anti-inflammatory drugs and perioperative bleeding in paediatric tonsillectomy. Cochrane Database Syst Rev. 2013 Jul 18;(7):CD003591. doi: 10.1002/14651858.CD003591.pub3. Review.</citation>
    <PMID>23881651</PMID>
  </reference>
  <reference>
    <citation>Merry AF, Gibbs RD, Edwards J, Ting GS, Frampton C, Davies E, Anderson BJ. Combined acetaminophen and ibuprofen for pain relief after oral surgery in adults: a randomized controlled trial. Br J Anaesth. 2010 Jan;104(1):80-8. doi: 10.1093/bja/aep338.</citation>
    <PMID>20007794</PMID>
  </reference>
  <reference>
    <citation>Miranda HF, Puig MM, Prieto JC, Pinardi G. Synergism between paracetamol and nonsteroidal anti-inflammatory drugs in experimental acute pain. Pain. 2006 Mar;121(1-2):22-8. Epub 2006 Feb 9.</citation>
    <PMID>16480830</PMID>
  </reference>
  <reference>
    <citation>Gardiner P, Dvorkin L. Promoting medication adherence in children. Am Fam Physician. 2006 Sep 1;74(5):793-8. Review.</citation>
    <PMID>16970023</PMID>
  </reference>
  <reference>
    <citation>Haynes RB, McKibbon KA, Kanani R. Systematic review of randomised trials of interventions to assist patients to follow prescriptions for medications. Lancet. 1996 Aug 10;348(9024):383-6. Review. Erratum in: Lancet 1997 Apr 19;349(9059):1180.</citation>
    <PMID>8709739</PMID>
  </reference>
  <reference>
    <citation>Uitti JM, Salanterä S, Laine MK, Tähtinen PA, Ruohola A. Adaptation of pain scales for parent observation: are pain scales and symptoms useful in detecting pain of young children with the suspicion of acute otitis media? BMC Pediatr. 2018 Dec 20;18(1):392. doi: 10.1186/s12887-018-1361-y.</citation>
    <PMID>30572868</PMID>
  </reference>
  <verification_date>October 2021</verification_date>
  <study_first_submitted>September 9, 2020</study_first_submitted>
  <study_first_submitted_qc>September 9, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">September 16, 2020</study_first_posted>
  <last_update_submitted>October 1, 2021</last_update_submitted>
  <last_update_submitted_qc>October 1, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">October 5, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Tonsillitis</mesh_term>
    <mesh_term>Pain, Postoperative</mesh_term>
    <mesh_term>Hypertrophy</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Acetaminophen</mesh_term>
    <mesh_term>Ibuprofen</mesh_term>
  </intervention_browse>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

